Research Article

Experimental pharmacology assessment of Agave brittoniana subsp. brachypus (Trel.) in ulcerative colitis

Volume: 28 Number: 6 June 28, 2025
  • Yisel González-madariaga *
  • Dayli Santiestfban-muñoz
  • Leisy Nieto-reyes
  • María L. García-gómez
  • José O. Guerra De León
EN

Experimental pharmacology assessment of Agave brittoniana subsp. brachypus (Trel.) in ulcerative colitis

Abstract

Ulcerative colitis is a chronic inflammatory bowel disease with an unknown cause. It is characterized by damage to the colonic mucosa, which often results in symptoms such as diarrhea, abdominal pain, and weight loss, ultimately leading to a reduced quality of life. Treatment aims to control inflammation, reduce symptoms, and minimize fluid and nutrient losses. Currently, there is no known cure for ulcerative colitis. The study was carried out to investigate the anti-inflammatory potential of the hydroalcoholic extract (HAE) and the butanolic fraction (FB) from Agave brittoniana subsp. brachypus (Trel.) on acetic acid-induced colitis in rats. Ulcerative colitis was induced in Sprague Dawley rats using 2.5% acetic acid. Three dose levels for both HAE (150-300-600 mg/kg) and BF (25-50-100 mg/kg) were evaluated. The study recorded the variation of body weight, macroscopic and microscopic colonic damage index, and colonic myeloperoxidase. Body weight loss was lower in all treated groups compared to the untreated group. Similarly, there were fewer signs of necrosis and tissue damage in the colon in the groups treated with HAE and BF. Agave brittoniana T exhibited an effective anti-inflammatory effect in an experimental model of ulcerative colitis, indicating its potential as a natural treatment for the condition.

Keywords

References

  1. [1] Armuzzi A, Liguori G. Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: a narrative review. Dig Liver Dis. 2021;53(7):803-808 . https://doi.org/10.1016/j.dld.2021.03.002
  2. [2] Raine T, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V, Bachmann O, Bettenworth D, Chaparro M, Czuber-Dochan W, Eder P, Ellul P, Fidalgo C, Fiorino G, Gionchetti P, Gisbert JP, Gordon H, Hedin C, Holubar S, Iacucci M, Karmiris K, Katsanos K, Kopylov U, Lakatos PL, Lytras T, Lyutakov I, Noor N, Pellino G, Piovani D, Savarino E, Selvaggi F, Verstockt B, Spinelli A, Panis Y, Doherty G. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. J Crohns Colitis. 2022;16(1):2-17. https://doi.org/10.1093/ecco-jcc/jjab178
  3. [3] Thiede J, Eggli U. Agavaceae. In: Eggli U, Nyffeler R. (eds) Monocotyledons. Illustrated Handbook of Succulent Plants. 2020. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-56486-8_112
  4. [4] Torres IG, Rendón FSJ, Blancas J, Moreno AIC. The genus Agave in agroforestry systems of Mexico. Bot. Sci. 2019; 97(3): 263-290. https://doi.org/10.17129/botsci.2202.
  5. [5] Eguiarte LE, Jiménez Barrón OAB, Aguirre E, Scheinvar E, Gámez N, Gasca JP, Souza V. Evolutionary ecology of Agave: distribution patterns, phylogeny, and coevolution (an homage to Howard S. Gentry). Am J Bot. 2021; 108(2):216-235. https://doi.org/10.1002/ajb2.1609
  6. [6] Alducin CM, Ruiz KM, Jiménez OB, Aguirre Planter EP, Gasca JP, Eguiarte LE, Medellin RA. Uses, knowledge and extinction risk faced by agave species in Mexico. Plants. 2023; 12: 124. https://doi.org/ 10.3390/plants12010124
  7. [7] Eguiarte L, Souza V, Silva AM. Evolución de la familia Agavaceae: Filogenia, biología reproductiva y genética de poblaciones. Bot Sci. 2000; 66:131-150. https://doi.org/10.17129/botsci.1618
  8. [8] POWO. Plants of the World Online. Facilitated by the Royal Botanic Gardens, Kew. http://www.plantsoftheworldonline.org/ (accessed on consulted 7 February 2024).

Details

Primary Language

English

Subjects

Pharmaceutical Toxicology

Journal Section

Research Article

Authors

Yisel González-madariaga * This is me
0000-0002-0461-0741
Cuba

Dayli Santiestfban-muñoz This is me
0000-0003-4756-4148
Cuba

Leisy Nieto-reyes This is me
0000-0003-3504-337X
Cuba

María L. García-gómez This is me
0000-0002-1219-0193
Cuba

José O. Guerra De León This is me
0000-0002-6885-5481
Cuba

Publication Date

June 28, 2025

Submission Date

August 24, 2023

Acceptance Date

February 14, 2024

Published in Issue

Year 2024 Volume: 28 Number: 6

APA
González-madariaga, Y., Santiestfban-muñoz, D., Nieto-reyes, L., García-gómez, M. L., & Guerra De León, J. O. (2025). Experimental pharmacology assessment of Agave brittoniana subsp. brachypus (Trel.) in ulcerative colitis. Journal of Research in Pharmacy, 28(6), 1963-1973. https://doi.org/10.29228/jrp.870
AMA
1.González-madariaga Y, Santiestfban-muñoz D, Nieto-reyes L, García-gómez ML, Guerra De León JO. Experimental pharmacology assessment of Agave brittoniana subsp. brachypus (Trel.) in ulcerative colitis. J. Res. Pharm. 2025;28(6):1963-1973. doi:10.29228/jrp.870
Chicago
González-madariaga, Yisel, Dayli Santiestfban-muñoz, Leisy Nieto-reyes, María L. García-gómez, and José O. Guerra De León. 2025. “Experimental Pharmacology Assessment of Agave Brittoniana Subsp. Brachypus (Trel.) in Ulcerative Colitis”. Journal of Research in Pharmacy 28 (6): 1963-73. https://doi.org/10.29228/jrp.870.
EndNote
González-madariaga Y, Santiestfban-muñoz D, Nieto-reyes L, García-gómez ML, Guerra De León JO (July 1, 2025) Experimental pharmacology assessment of Agave brittoniana subsp. brachypus (Trel.) in ulcerative colitis. Journal of Research in Pharmacy 28 6 1963–1973.
IEEE
[1]Y. González-madariaga, D. Santiestfban-muñoz, L. Nieto-reyes, M. L. García-gómez, and J. O. Guerra De León, “Experimental pharmacology assessment of Agave brittoniana subsp. brachypus (Trel.) in ulcerative colitis”, J. Res. Pharm., vol. 28, no. 6, pp. 1963–1973, July 2025, doi: 10.29228/jrp.870.
ISNAD
González-madariaga, Yisel - Santiestfban-muñoz, Dayli - Nieto-reyes, Leisy - García-gómez, María L. - Guerra De León, José O. “Experimental Pharmacology Assessment of Agave Brittoniana Subsp. Brachypus (Trel.) in Ulcerative Colitis”. Journal of Research in Pharmacy 28/6 (July 1, 2025): 1963-1973. https://doi.org/10.29228/jrp.870.
JAMA
1.González-madariaga Y, Santiestfban-muñoz D, Nieto-reyes L, García-gómez ML, Guerra De León JO. Experimental pharmacology assessment of Agave brittoniana subsp. brachypus (Trel.) in ulcerative colitis. J. Res. Pharm. 2025;28:1963–1973.
MLA
González-madariaga, Yisel, et al. “Experimental Pharmacology Assessment of Agave Brittoniana Subsp. Brachypus (Trel.) in Ulcerative Colitis”. Journal of Research in Pharmacy, vol. 28, no. 6, July 2025, pp. 1963-7, doi:10.29228/jrp.870.
Vancouver
1.Yisel González-madariaga, Dayli Santiestfban-muñoz, Leisy Nieto-reyes, María L. García-gómez, José O. Guerra De León. Experimental pharmacology assessment of Agave brittoniana subsp. brachypus (Trel.) in ulcerative colitis. J. Res. Pharm. 2025 Jul. 1;28(6):1963-7. doi:10.29228/jrp.870